Medicinally used hemp products are subject to strict control, as they are medicinal products – in this case even with narcotic status.
Below you will find publications on the subject of medicinal cannabis and hemp products:
A. Pohl, Guest article in “krautinvest” (Jun 2022):
Anforderungen an die Analytik von Cannabisblüten, https://krautinvest.de/anforderungen-an-die-analytik-von-cannabisblueten/
Tentamus Group GmbH
CBD products: QSI Offers Legal Consulting
PresseBox (unn | UNITED NEWS NETWORK GmbH), Berlin, 18.November (2021)
Tentamus Group GmbH
Tentamus erleichtert den globalen Hanfhandel mit validierten Tests
PresseBox (unn | UNITED NEWS NETWORK GmbH), Berlin, 17.Juni (2021)
T. Wiezorek, Guest article in “krautinvest” (Jun 2018):
Pflicht: Analysen für medizinisches Cannabis; https://krautinvest.de/pflicht-analysen-fuer-medizinisches-cannabis/
Please feel free to contact us if you have any questions.
Email: info.qsi@tentamus.com (hemp products)
Email: gmp.qsi@tentamus.com (medical cannabis)
Phone: +49 (0)421 / 59 66 070
Contact from